Literature DB >> 20331460

Guidelines for the management of vulvodynia.

D Nunns1, D Mandal, M Byrne, J McLelland, R Rani, J Cullimore, D Bansal, F Brackenbury, G Kirtschig, M Wier.   

Abstract

These guidelines for the management of vulvodynia have been prepared by the British Society for the Study of Vulval Diseases Guideline Group. They present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines.
© 2010 The Authors. Journal Compilation © 2010 British Association of Dermatologists.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20331460     DOI： 10.1111/j.1365-2133.2010.09684.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  16 in total

1.  Remission, Relapse, and Persistence of Vulvodynia: A Longitudinal Population-Based Study.

Authors:  Barbara D Reed; Sioban D Harlow; Melissa A Plegue; Ananda Sen
Journal:  J Womens Health (Larchmt)       Date:  2016-01-11       Impact factor: 2.681

2.  Toll-Like Receptor Signaling Contributes to Proinflammatory Mediator Production in Localized Provoked Vulvodynia.

Authors:  Megan L Falsetta; David C Foster; Collynn F Woeller; Stephen J Pollock; Adrienne D Bonham; Dorota Piekna-Przybylska; Sanjay B Maggirwar; Constantine G Haidaris; Richard P Phipps
Journal:  J Low Genit Tract Dis       Date:  2018-01       Impact factor: 1.925

3.  Myotonometry Reliably Measures Muscle Stiffness in the Thenar and Perineal Muscles.

Authors:  Melissa J Davidson; Adam L Bryant; Wendy F Bower; Helena C Frawley
Journal:  Physiother Can       Date:  2017       Impact factor: 1.037

4.  A Role for Bradykinin Signaling in Chronic Vulvar Pain.

Authors:  Megan L Falsetta; David C Foster; Collynn F Woeller; Stephen J Pollock; Adrienne D Bonham; Constantine G Haidaris; Richard P Phipps
Journal:  J Pain       Date:  2016-08-18       Impact factor: 5.820

Review 5.  A review of the available clinical therapies for vulvodynia management and new data implicating proinflammatory mediators in pain elicitation.

Authors:  M L Falsetta; D C Foster; A D Bonham; R P Phipps
Journal:  BJOG       Date:  2016-06-17       Impact factor: 6.531

6.  The histopathological results of vestibulectomy specimens in localized provoked vulvodynia in Turkey.

Authors:  Suleyman Eserdag; Didem Kurban; Mine Kiseli; Murat Alan; Yasemin Alan
Journal:  Pan Afr Med J       Date:  2020-11-24

7.  Specialized Pro-resolving Mediators Reduce Pro-nociceptive Inflammatory Mediator Production in Models of Localized Provoked Vulvodynia.

Authors:  Megan L Falsetta; Ronald W Wood; Mitchell A Linder; Adrienne D Bonham; Kenneth V Honn; Krishna Rao Maddipati; Richard P Phipps; Constantine G Haidaris; David C Foster
Journal:  J Pain       Date:  2021-04-01       Impact factor: 5.383

8.  A comparison of cognitive-behavioral couple therapy and lidocaine in the treatment of provoked vestibulodynia: study protocol for a randomized clinical trial.

Authors:  Serena Corsini-Munt; Sophie Bergeron; Natalie O Rosen; Marc Steben; Marie-Hélène Mayrand; Isabelle Delisle; Pierre McDuff; Leen Aerts; Marie Santerre-Baillargeon
Journal:  Trials       Date:  2014-12-23       Impact factor: 2.279

9.  Differentiating overlapping symptoms of vulvodynia and pudendal neuralgia.

Authors:  Anna Ghizzani; Serafino Carta; Annalisa Casoni; Paolo Ferrata; Stefano Luisi; Mattia Fortina
Journal:  Br J Pain       Date:  2018-05-15

Review 10.  Female reproductive tract pain: targets, challenges, and outcomes.

Authors:  Phillip Jobling; Kate O'Hara; Susan Hua
Journal:  Front Pharmacol       Date:  2014-02-13       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.